P acemapping has been shown to be useful in determining the site of origin or exit site of ventricular arrhythmias (VA) in both idiopathic and scar-related etiologies, particularly, when sustained ventricular tachycardia (VT) is poorly tolerated or ventricular ectopy (VE) occurs at a low frequency.
Mapping Protocol
All studies were performed on patients in the fasting state and whose antiarrhythmic drug therapy was discontinued for at least 5 half-lives, except in patients with VT storm or those on amiodarone. Scar-dependent VT ablation was performed under general anesthesia and VE cases under light sedation. Sub-xiphoid epicardial approach was undertaken based on clinical etiology, data from preprocedural imaging, or prior procedural mapping. In general, dual left ventricular (LV) access using trans-septal and retrograde aortic approach was used in scar-dependent VT cases. In cases where catheter reach or contact was deemed to be poor, a steerable sheath (Agilis NxT; St Jude Medical, St Paul, MN) was used. Anticoagulation during LV procedures was maintained with unfractionated heparin. Participants were studied in a biplane fluoroscopic laboratory with ECG electrodes placed in a standard configuration. Patients underwent electroanatomical mapping using the Ensite Velocity System (St Jude Medical). Correction for respiratory motion was routinely applied at the start of the case. Surface ECG and intracardiac electrograms were simultaneously recorded and logged on Labsystem Pro software (Bard Electrophysiology, Lowell, MA). All studies were performed with surface ECG filter settings at 0.5 to 100 Hz with a 50 Hz notch filter enabled. Bipolar electrograms were recorded with filter settings at 30 to 300 Hz. Multipolar catheters were introduced into the coronary sinus and right ventricle (RV) in all cases. Mapping data were continuously recorded on the Ensite Velocity platform (St Jude Medical) to allow data extraction and postprocessing.
Mapping and ablation were performed with a 3.5-mm open-irrigated radiofrequency ablation catheter, with 2 mm interelectrode distance (ThermoCool SF; Biosense-Webster, Diamond Bar, CA). For VT cases, voltage mapping was performed during sinus rhythm concentrating on areas of abnormal voltage, with a fill threshold of 10 mm at the outset with established definitions used to determine normal myocardium (>1.5 mV), border zone (0.5-1.5 mV), and dense scar (<0.5 mV). For VE cases, voltage mapping was performed where there was a clinical suspicion of structural abnormalities.
If there was infrequent ectopy at baseline, intravenous isoprenaline infusion was used and titrated according to response.
Pacing point collection was performed during sinus rhythm from the distal bipolar pair of the mapping catheter. Adequate contact and stability was judged by a combination of fluoroscopic appearance, proximity to the geometry surface, and electrogram amplitude and morphology consistency. Pacing was performed at 2 ms pulse width at a cycle length or coupling interval equal to the clinical VA or if hemodynamically unstable at that rate or unknown, at 400 ms. Pacing was initiated at low output and increased and continued until ≥3 consecutive captured beats with identical morphology were obtained. Pacing sites were restricted to areas of myocardium >0.5 mV as displayed on the voltage map and were initially distributed widely then focused in on the putative site of origin or exit site of the targeted VA. Geometry, pacing site location, and ECG morphology data were exported from the mapping system and imported into custom software for offline analysis.
Data Analysis
Sinus rhythm intracardiac electrograms from the beat preceding each pacing train were analyzed post-procedure. Electrogram amplitude and morphology characteristics were recorded and defined as follows: fractionated (multiple intrinsic deflections [>3 sharp deflections], amplitude ≤0.5 mV, duration ≥133 ms, and amplitude:duration ≤0.005 mV/ms); late (isolated component ≥20 ms after the end of surface QRS); and split potential (a double component electrogram within the QRS inscription separated by an isoelectric line). 3 Stimulation to QRS onset interval and electrogram duration were measured using electronic calipers at 200 mm/s sweep speed.
In essence, the paced QRS morphology from a single pacing site was quantitatively compared with the paced QRS morphology from a second pacing site and the difference plotted against the distance between the pacing sites that generated the 2 QRS morphologies. Each pacing point collected was compared against all other pacing sites within the same procedure such that all possible pair combinations were included. Distances were measured automatically by custom software run on the Ensite Velocity platform (St Jude Medical) and were taken as the direct Euclidean distance between 2 points in 3-dimensional space as shown in Equation 1 . 
To quantify the difference in morphology between surface ECGs generated by distinct pacing sites, the ECG signal underwent post-processing by superimposing the QRS complexes, and then alignment was achieved using the maximum of the 12-lead composite signal (maximum energy) and then verified visually. The composite signal was taken as the addition of the sum of the absolute values of all used leads at each time point for each pacing site. The alignment that maximizes this value is then used to compute the morphological difference. The root mean square error (E) parameter was used to compare the surface ECGs between 2 sites and is expressed in mV. In typical use, E is a comparative measure between 2 individual waveforms. To compare all 12 ECG leads (E12) simultaneously, the definition of E can be extended by summing the E value for each of the 12 leads to obtain the E12 as shown in Equation 2, where i represents one of the leads in the 12-lead ECG, and j represents each recorded time point in the ECG data set up to a total of N time points. The voltages with respect to the isoelectric line are represented by V, where V and V r represent 2 pacemap points being compared. 
The value of E12 is zero for identical 12-lead ECG tracings and increasingly larger for data sets that have greater dissimilarity, thus, providing a direct measure of the similarity between 2 ECG traces. Two examples of the relationship between E12 and QRS morphology are shown in Figure 1 . An example distance-E12 data set from a single patient is shown in Figure 2 .
In our previous work (unpublished), several quantitative measures were used to construct the distance similarity graphs. Use of the E12 parameter provided the highest correlation values when compared with the most commonly used measure-the correlation coefficient (Corr). In contrast to the Corr, the E12 parameter theoretically has no upper limit and, therefore, provides better quantification of the
WHAT IS KNOWN
• Pacemapping is an established method for identifying the exit site of ventricular arrhythmias.
• The relationship between distance and change in morphology is the basis of pacemapping, but this has not been systematically quantified.
WHAT THE STUDY ADDS
• This study has shown that the change in surface ECG morphology between pacing points as measured by E12 is strongly and predictably related to distance when restricted to nonscar areas.
• The relationship remains robust across a population with structurally normal and abnormal hearts and within both ventricles.
• There are differences in the resolution of pacemapping between cardiac chambers. morphology difference between pacing sites that are furthest apart and would, therefore, be expected to be most dissimilar.
To analyze the effect of various parameters on the distance-E12 relationship, continuous data were transformed into categorical data based on predefined cutoffs. As each E12-distance point is generated from 2 discrete pacing sites, the effect of an abnormal parameter at either one of the pacing sites or at both pacing sites was analyzed separately to determine the presence of an effect on the E12-distance relationship.
Electrogram duration was defined as abnormal if >56 ms and stimulation to QRS onset as abnormal if >40 ms. 4, 5 We designated a pacing threshold >8 mV at 2 ms pulse width as abnormal, which represented values above the 90th centile in our normal heart cohort.
Statistical Analysis
Statistical analysis was performed with R version 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria) and STATA version 13.0 (StataCorp, College Station, TX). The distribution of continuous variables was assessed for normality using the ShapiroWilk test. Comparisons between groups of continuous data were performed by t test after controlling for equality of variance with Levene's test. Non-normal distributed variables were analyzed with Mann-Whitney U test, and categorical data were compared with the Chi-square test. To account for the within-patient variation because of repeated measurements of each patient and remove the multiple testing bias, univariable and multivariable linear mixed-effects models with unstructured covariance matrix, using patient identification as random effect, were used to investigate the factors associated with E12. The linear mixed-effects models provided regression coefficients and 95% confidence intervals (CIs) of the effect of each of the factors on E12 (mV). Ggplot2 plotting system for R and 2-way scatter plots in STATA were used to illustrate the association of E12 with distance. For the multivariable model, variables found univariably significant (see Data Supplement) were entered in the linear A B Figure 1 . A, Two pacemap points in close proximity to each other are compared. B, The same pacemap point (dotted line) is compared with a more distant pacemap (solid line) and has a larger E12. E12 indicates the root mean square error sum across 12 ECG leads.
mixed-effects model. When analyzing the effect of pacing and electrogram characteristics at pacing sites on E12, where univariable analysis demonstrated a significant association with an abnormal parameter that occurred in either and both pacing points in the pair, either was placed into the multivariable model, and if this was nonsignificant, the model was rerun to include an abnormal parameter in both pacing points in the pair. Receiver operator curve analysis was performed to determine cutoff values of E12 to predict correlation template matches of 90% and 95%, representing good and excellent 12-lead QRS morphology matches, respectively. P<0.05 was considered to be statistically significant.
Results
Patient demographics are shown in Table 1 . Median age of the cohort was 59 years (interquartile range, 28) and was predominantly male (68%). Overall, 40 (58%) of patients had structurally abnormal hearts, with the predominant etiology being ischemic (53%). In contrast to those with normal hearts, those with structural heart disease were predominantly male (88% versus 39%), were older (61 [SD=15] years versus 49 [SD=16] years), and had significantly more comorbidities, including higher New York Heart Association class, more renal disease (creatinine 100 [SD=43] g/dL versus 72 [SD=13] g/dL), lower ejection fraction (42% [SD=14] versus 58% [SD=7]), more atrial fibrillation (28% versus 4%), more implanted devices (100% versus 3%), higher amiodarone (40% versus 0%), and heart failure medication use.
In total, 74 procedures were performed, of which 44 (59%) were undertaken in structurally abnormal hearts. In contrast to procedures on normal hearts, procedures for patients with structural abnormalities were performed predominantly for VT (64% versus 20%) and were mainly indicated for reduction or prevention of implantable cardioverter defibrillator (ICD) shocks (59% versus 4%) and performed largely under general anesthesia (82% versus 27%). Endocardial-only approach was undertaken in 69 (93%) patients.
Mapping data are shown in Table 2 . Two patients in the normal heart cohort underwent voltage mapping. All patients with structural heart disease underwent voltage mapping with a median of 112 points (interquartile range, 160) acquired. Overall, 935 pacing sites were analyzed, of which 440 (47%) pacing points were performed in the LV, 197 (21%) in the RV, 157 (17%) in the right ventricular outflow tract (RVOT), and 82 (9%) in the left ventricular outflow tract (LVOT). A total of 59 (6%) pacing points were collected from the epicardium, of which 30 were from the epicardial LV. These generated 6219 paired combinations, which were used to evaluate the distance-E12 relationship; of these, 2334 (38%) were LV pairs, 753 (12%) were RV pairs, 430 (7%) were RVOT pairs, 326 (5%) were LVOT pairs, and 162 (3%) were epicardial pairs. The remainder were combinations across chambers. Median distances between pacing sites was 32 mm (range 0.91-233; interquartile range, 28). Median E12 between pacing sites was 5.65 mV (range 0.56-19.76; interquartile range, 4).
Comparison of E12 to Correlation Coefficient
Receiver operator curve analysis was used to establish cutoffs for E12. Using an E12 cutoff of <3.88 had a sensitivity of 90% and specificity of 81% for predicting a Corr match of ≥90% (area under the curve 0.934; 95% CI 0.92-0.95; P<0.001). An E12 cutoff of <3.30 had a sensitivity of 92% and specificity of 86% for predicting a Corr match of ≥95% (area under the curve 0.951; 95% CI 0.94-0.96; P<0.001).
Variables Affecting E12-Distance Relationship
Full univariable analyses are shown in the Data Supplement. For the multivariable analysis, variables that were adjusted for included distance, location, electrogram duration, stimulation to QRS interval, electrogram amplitude <0.5 mV, the presence of split potentials, and COPD.
Effect of Distance on E12
The overall distance-E12 relationship is shown in Figures 3 and  4 . Using linear mixed-effects modeling, multivariable analysis demonstrated a significant positive association of distance with similarity as measured by E12 (0.07 per mm; 95% CI 0.07-0.08; P<0.001), such that per millimeter increase in distance, E12 increased by 0.07. When analyzed by distance categories, 
the association was significant between 10 and 50 mm, with the highest E12 change per millimeter distance between 10 and 20 mm, estimate 0.13 (95% CI 0.10-0.17; P≤0.001).
Effect of Patient Demographics on E12
Of the demographic variables, only the presence of chronic obstructive pulmonary disease demonstrated a significant association with increased E12 values, estimate 1.43; 95% CI 0.21-2.66; P=0.02. Neither the presence of structural heart disease and left ventricular ejection fraction nor the periprocedural use of antiarrhythmic therapy was significantly associated with changes in E12.
Effect of Location on E12
When analyzing E12 values by location, small differences were seen (Figure 4) 
Effect of Underlying Substrate on E12
The frequency of abnormal electrograms seen during sinus rhythm just prior to onset of pacing is shown in full in Table II in the Data Supplement. In multivariable analysis, only stimulation to QRS onset interval >40 ms in either pacing site of the pair remained associated with higher E12 values (0.24; 95% CI 0.12-0.36; P<0.001). The presence of split potentials at either pacing site of the pair was associated with lower E12 values (−0.51; 95% CI −0.74 to −0.27; P<0.001). Neither pacing threshold >8 mA and low electrogram amplitude (<1.5 or <0.5 mV) nor electrogram duration >56 ms was shown to be associated with E12 in multivariable analysis.
Discussion
The main findings from this study are the following:
1. The change in surface ECG morphology between pacing points as measured by E12 is strongly and predictably related to distance when restricted to nonscar areas and remains robust across a population with structurally normal and abnormal hearts and within both ventricles. 2. There are differences in the resolution of pacemapping between cardiac chambers.
Relationship Between Distance and Change in Morphology
The E12-distance relationship was seen to be remarkably robust throughout the population, with few variables seen to affect this relationship. Most notable is the lack of association with the presence of or burden of scar as evaluated by LV ejection fraction. This may be partly explained by the protocol ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; AF, atrial fibrillation; BSA, body surface area; COPD, chronic obstructive pulmonary disease; CRT-D, cardiac resynchronization therapydefibrillator; CRT-P, cardiac resynchronization therapy-pacemaker; CVA, cerebrovascular accident; DCM, dilated cardiomyopathy; HT, hypertension; ICD, implantable cardioverter defibrillator; and NYHA, New York Heart Association. *P<0.05.
whereby we intended to limit pacing to sites free of scar and, thus, represented initial breakout and conduction through predominantly normal tissue. While we aimed to pace within tissue >0.5 mV, guided by the voltage map appearance in scar cases and assumed in normal hearts, unintentional pacing in scar may have occurred because the fill threshold was set to 10 mm on the color map, and subtle scar may have been missed on conventional imaging. However, even when inadvertent pacing within scar occurred, evidenced by low-amplitude electrograms, no effect on E12 was seen. Of the abnormal electrogram criteria analyzed, only pacing latency was shown to be significantly associated with higher E12 values and could be explained by the longer path taken by the activation wavefront through an isthmus or around a line of conduction block such that the breakout occurs at a distance from the catheter tip. The association of split potentials and lower E12 values is difficult to explain but may be accounted for by the position of the catheter tip and the breakout of the activation wavefront relative to a line of block. The positive association between the presence of COPD and higher E12 values is interesting and may suggest that a chest with a higher volume can alter the relationship. However, the association with BMI was not significant and so may not be fully accounted for by chest surface area alone, but may be more influenced by the ratio of heart size to chest volume. Prior studies have reported on this relationship using semiquantitative scoring systems in the RVOT. 2, 6, 7 Only one other study has attempted to quantify this relationship using the Corr during sequential unipolar pacing from a quadripolar catheter with 5 mm interelectrode distance positioned within the RV apex. That study demonstrated a mean decrease of 3% in the Corr per millimeter distance using the paced ECG morphology from the distal pole as the reference. 
Resolution of Pacemapping
Analysis of our data stratified by distance indicates that the relationship is strongest for pacing sites within a distance of 10 to 50 mm. The greatest change in E12 per millimeter distance is within the 10 to 20 mm range. Below 10 mm and >50 mm, the association becomes nonsignificant. These data are in keeping with the limited existing data on the resolution of pacemapping to identify the exit site or site of origin of a VA, using the standard surface ECG configuration. In the study by Azegami et al, 6 semiquantitative ECG morphology analysis established that the mean maximum distance between best pacemap match points in the RVOT of patients undergoing ablation for idiopathic VA was 18±5 mm (range 11-26 mm). In another study, the spatial resolution of pacemapping in the RVOT in a similar group of patients was 1.8±0.6 cm 2 when considering morphologies with ≥11/12 leads that matched. 2 In the only study reporting spatial resolution of pacemapping in the LV, Sinno et al 9 performed pacemapping restricted to areas of endocardial voltage <1.5 mV in patients undergoing ablation for ischemic VT. The investigators established that the area in which matching pacemaps ≥10/12 leads can be achieved was 3.86±1.9 cm 2 at exit sites within border zone tissue and 1.41±1.6 cm 2 for nonexit sites within dense scar. 9 In contrast to our protocol, where areas of preserved voltage were targeted for pacing, the study by Sinno et al 9 concentrated pacemapping efforts in areas of abnormal voltage <1.5 mV and were, thus, likely to have captured isthmus sites where morphology matches could be found but where pacing latency could be prolonged, increasing the area where similar pacemap matches could be found.
To our knowledge, there is currently no reported data comparing the resolution of pacemapping in different areas of the heart. Our data suggests that differences exist between and within chambers, although it is unclear what effect clinically these differences have. When compared with pacing site pairs in the LV, E12 values were significantly lower in the RV and LVOT, suggesting a lower spatial resolution. Little data exist for morphology mapping in the RV beyond a small number of case series. However, the RV is fundamentally different in structure, being thin-walled, asymmetrical, and deformable and in a more anterior position within the chest cavity. Because the RV-free wall comprises the majority of the endocardial RV surface area and abuts the anterior chest wall, this may limit the vector of excitation away from the chest wall electrodes and, thus, reduce the range of morphology changes throughout the cavity when compared with the LV, which lies more centrally within the chest. Differences in outflow tract compared with the ventricular body in the LV but not the RV could be explained by preferential conduction pathways within the aortic cusps. In support of this hypothesis, analysis of our data for stimulation to QRS onset times showed pacing latency was significantly longer in the LVOT compared with the RVOT (P<0.001).
When comparing values across chambers, adjusted E12 estimates were higher in LV-RV pairs compared with LV pairs but no different in LVOT-RVOT pairs compared with RVOT pairs. Higher adjusted E12 values may indicate more abrupt changes in morphology across the interventricular septum, which in this instance is likely to be because of a change in bundle branch morphology, supported by evidence from VT mapping studies involving septal tachycardias. 10 In contrast, mapping data from the outflow tracts suggest a more continuous change in ECG morphology between outflow tracts in both the frontal plane axis and precordial transition, consistent with our findings.
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Clinical Implications
Considerable experience is required to determine a next suitable site to achieve a closer pacemap match. In practice, sites are selected arbitrarily, and the process repeated iteratively until the closest pacemap match is achieved, which is timeinefficient and can have negative implications for the patient and physician. Quantifying how much the surface ECG morphology changes per unit distance and showing its consistency across a mixed population of patients could lead to improvements in the pacemapping process, whereby mapping could become automated. With this knowledge, one could envisage an automated system that could use the E12-distance relationship graph in an individual patient to predict the distance from an existing pacing site that the exit site of a VT/VE resides by their morphological difference. In this manner, when using 3 pacing points, the exit site can be triangulated. Differences in spatial resolution within different cardiac chambers may be because of limitations imposed by the current ECG recording technique that may be optimized by the addition of further leads, potentially reducing the area of ablation and time required to achieve a successful outcome.
Limitations
Pacing in bipolar mode and with a 3.5 mm tip ablation catheter may have resulted in capture of a larger area of myocardium than during unipolar pacing or pacing from catheters with small-size electrodes. The use of noncontact forcesensing catheters may have potentially resulted in underestimation of the local electrogram amplitude and, thus, the overestimation of scar in certain areas where adequate contact is difficult to achieve. However, care was taken to ensure good contact, using both transaortic and transmitral access to the LV and taking voltage points with a single bipole after scrutinizing each for its quality. All low-voltage sites were confirmed with high-density point collection locally to minimize the chance of poor contact creating false scar. Although complete electroanatomic maps were performed in patients with documented cardiomyopathy, these were not routinely performed in the cohort with normal cardiac structure and function on preprocedural imaging, and so small areas of scar not detected by conventional imaging modalities because of subtle cardiomyopathic processes may have been missed.
Conclusions
We have shown that a robust and predictable positive relationship exists between distance and ECG morphological change as measured by root mean square error when restricting pacing sites to areas of myocardial voltage >0.5 mV in both structurally normal and abnormal hearts. This may lead to improvements in pacemapping when used as part of an automated navigation system where the relationship could be used to determine the distance a mapping catheter should be moved to produce a certain change in ECG morphology. Differences in spatial resolution within different cardiac chambers exist and maybe because of limitations imposed by the current ECG recording technique. 
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